InvestorsHub Logo
Followers 0
Posts 138
Boards Moderated 0
Alias Born 08/12/2016

Re: None

Friday, 05/12/2017 1:11:09 PM

Friday, May 12, 2017 1:11:09 PM

Post# of 5004
1) Anyone take note that the RXI-231 (skin-lightener) human testing has been delayed - yet again? This, after Pavco emphatically stated in the 3/30 CC that testing would begin in early April.

2) Not unexpectedly (due to no new data until H2), there was virtually no substance in yesterday's CC.

3) I found Eliseev's remarks to be enlightening (at least, to me) regarding the interest shown by outside Big Pharma regarding the immuno-oncology drugs. But let's be honest: it was more like warm fuzzy words to soothe the Nervous Nellies (ie, retail investors).

4) And judging by today's lackluster market action, the general public is saying, "meh".
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PHIO News